Design, synthesis, and evolution of a novel, selective, and orally bioavailable class of thrombin inhibitors: P1-argininal derivatives incorporating P3-P4 lactam sulfonamide moieties.
Semple JE, Rowley DC, Brunck TK, Ha-Uong T, Minami NK, Owens TD, Tamura SY, Goldman EA, Siev DV, Ardecky RJ, Carpenter SH, Ge Y, Richard BM, Nolan TG, Håkanson K, Tulinsky A, Nutt RF, Ripka WC.
Semple JE, et al. Among authors: nutt rf.
J Med Chem. 1996 Nov 8;39(23):4531-6. doi: 10.1021/jm960572n.
J Med Chem. 1996.
PMID: 8917639
No abstract available.